Free Trial

Algert Global LLC Acquires Shares of 7,383 Red Violet, Inc. (NASDAQ:RDVT)

Red Violet logo with Computer and Technology background

Algert Global LLC acquired a new stake in Red Violet, Inc. (NASDAQ:RDVT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 7,383 shares of the company's stock, valued at approximately $267,000. Algert Global LLC owned 0.05% of Red Violet at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Barclays PLC increased its position in Red Violet by 240.7% during the 3rd quarter. Barclays PLC now owns 18,502 shares of the company's stock valued at $526,000 after purchasing an additional 13,072 shares during the period. JPMorgan Chase & Co. increased its position in Red Violet by 114.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 31,243 shares of the company's stock valued at $889,000 after purchasing an additional 16,661 shares during the period. Salem Investment Counselors Inc. increased its position in Red Violet by 202.7% during the 4th quarter. Salem Investment Counselors Inc. now owns 25,312 shares of the company's stock valued at $916,000 after purchasing an additional 16,951 shares during the period. Hennion & Walsh Asset Management Inc. acquired a new stake in Red Violet during the 4th quarter valued at approximately $232,000. Finally, Annex Advisory Services LLC acquired a new stake in Red Violet during the 4th quarter valued at approximately $1,080,000. Institutional investors and hedge funds own 63.56% of the company's stock.

Insider Transactions at Red Violet

In other news, insider Jeffrey Alan Dell sold 5,000 shares of the firm's stock in a transaction that occurred on Friday, May 9th. The shares were sold at an average price of $46.20, for a total transaction of $231,000.00. Following the completion of the sale, the insider now owns 172,968 shares of the company's stock, valued at $7,991,121.60. This trade represents a 2.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Steven D. Rubin sold 10,000 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $38.93, for a total transaction of $389,300.00. Following the sale, the director now directly owns 141,138 shares of the company's stock, valued at approximately $5,494,502.34. This trade represents a 6.62% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 25,000 shares of company stock valued at $1,082,400 in the last quarter. 9.50% of the stock is currently owned by company insiders.

Red Violet Trading Up 0.0%

NASDAQ:RDVT traded up $0.01 on Friday, reaching $49.20. 171,167 shares of the stock traded hands, compared to its average volume of 71,548. The firm has a market capitalization of $686.64 million, a price-to-earnings ratio of 136.67 and a beta of 1.69. The company's 50 day moving average is $39.15 and its 200-day moving average is $37.68. Red Violet, Inc. has a 1-year low of $19.76 and a 1-year high of $49.80.

Red Violet Company Profile

(Free Report)

Red Violet, Inc, a software and services company, specializes in proprietary technologies and applying analytical capabilities to deliver identity intelligence in the United States. It offers idiCORE, an investigative solution used to address various organizational challenges, which include due diligence, risk mitigation, identity authentication, fraud detection and prevention, customer acquisition, and regulatory compliance; and FOREWARN, an app-based solution that provides instant knowledge before face-to-face engagement with a consumer, as well as helps professionals to identify and mitigate risk.

Recommended Stories

Institutional Ownership by Quarter for Red Violet (NASDAQ:RDVT)

Should You Invest $1,000 in Red Violet Right Now?

Before you consider Red Violet, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Red Violet wasn't on the list.

While Red Violet currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines